Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
Invited review: Small GTPases and their GAPs.
A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health.
The importance of outcome measurement in orthopaedics.
CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.
See All 25 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.
Zage PE, Whittle SB, Shohet JM. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family. J Cell Biochem. 2017 02; 118(2):221-231.
View in:
PubMed
subject areas
Adrenal Gland Neoplasms
Animals
Antigens, CD
Biomarkers, Tumor
Humans
Neoplasm Proteins
Neoplastic Stem Cells
Neural Crest